Skip to main content
TLSI logo

TLSI

TriSalus Life Sciences, Inc.

$3.89

5.71%

Trade Ideas Performance

Latest Closed Trade Idea

$3.89

5.71%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

8

Social

28

About

Events of TriSalus Life Sciences, Inc. (TLSI)

Over the past six months, TriSalus Life Sciences' stock has been impacted by several events. The company reported earnings reports, including preliminary unaudited financial results for Q4 and full year 2025, and reaffirmed its 2026 revenue guidance. TriSalus announced its intention to offer and sell shares of its common stock in an underwritten public offering. Richard Marshall, M.D., was appointed as Chief Medical Officer, and Michael Stansky was appointed to the Board of Directors. TriSalus announced the publication of data demonstrating enhanced delivery and immune activation with Nelitolimod. As of April 10, 2026, the share price was $4.22, representing a decline compared to the previous year.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
TriSalus Life Sciences, Inc. (TLSI) Live Stock Price, Chart & Financial News | Edge Hound